---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-276021"
form_type: "8-K"
ticker: "NUVB"
cik: "0001811063"
company_name: "Nuvation Bio Inc."
filed_at: "2023-11-13T23:59:59+00:00"
generated_at: "2026-06-08T05:21:43.302872+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nuvation Bio CFO Jennifer Fox resigns effective Nov 27

## Summary
- CFO Jennifer Fox resigns to pursue a new opportunity; not due to any disagreement with the Company.
- Resignation effective November 27, 2023; no replacement named at this time.
- Executive management and finance team will assume CFO duties.

## SEC filing metadata
- accession: 0001193125-23-276021
- form_type: 8-K
- ticker: NUVB
- cik: 0001811063
- company_name: Nuvation Bio Inc.
- filed_at: 2023-11-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811063/000119312523276021/0001193125-23-276021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811063/000119312523276021/d312014d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-276021
- JSON: https://secwatch.observer/filing/0001193125-23-276021.json
- Plain text: https://secwatch.observer/filing/0001193125-23-276021.txt

## Key facts
- Executive change
  Jennifer Fox resigned as Chief Financial Officer at Nuvation Bio Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On November 9, 2023, Jennifer Fox, the Chief Financial Officer of Nuvation Bio Inc. (the “Company”), notified the Company of her decision to pursue a new opportunity and resign from her position at the Company effective November 27, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1811063/000119312523276021/0001193125-23-276021-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.